# RPG Life Sciences Ltd (RPGLIFE)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹2293.9
Day Change: +0.87%
52W High: ₹2725
52W Low: ₹1733
Market Cap: ₹3,805 Cr

## Valuation
P/E: 18.79
P/B: 6.29
EPS: ₹122.42
Book Value: ₹366.04
Dividend Yield: 1.05%

## Returns
1Y Return: 0.3%

## Profitability
ROE: 20.28%
ROCE: 30.6%
Debt/Equity: 0.03
Revenue Growth: 23.6%
Profit Growth: -74.5%
EBITDA Margin: 20.79%
Operating Margin: 15.31%

## About
RPG Life Sciences Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: RPG Life Sciences Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Compliances-Reg.24(A)-Annual Secretarial Compliance
- Concall Transcript: Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- BSE Filing: Compliances-Reg.24(A)-Annual Secretarial Compliance

## Data Freshness
Quote Updated: 2026-05-24T20:00:14.481Z
Price History Updated: 2026-05-25T05:31:22.207Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:31:22.207Z
Quant Updated: 2026-05-25T05:31:22.207Z
Sentiment Updated: 2026-05-25T05:31:22.207Z
Financials Status: current
Financials Updated: 2026-05-18T14:30:20.976Z
Financials Last Attempt: 2026-05-18T14:30:20.976Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2026)
Revenue: ₹653 Cr
Operating Profit: ₹160 Cr (OPM 24%)
Net Profit: ₹183 Cr
Tax: ₹233 Cr

## Balance Sheet (Mar 2026)
Total Assets: ₹658 Cr
Total Liabilities: ₹658 Cr
Borrowings: ₹0 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Ashok  Nair, MD & Additional Director
- Amol Narayan Lone, Chief Financial Officer
- Rajesh  Shirambekar, Head of Legal, Compliance Officer & Company Secretary
- Samir  Rane, Vice President of Sales & Marketing (Main Division)
- Sheetal  Gaba, Chief Human Resources Officer

---
Source: rupiya.io/stocks/rpglife
Disclaimer: For research and education only. Not investment advice.